I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Youling Gong
170
results:
Search for persons
X
Format
Online (170)
Mediatypes
Articles (Online) (84)
OpenAccess-fulltext (86)
Languages
english (132)
Sorted by: Relevance
Sorted by: Year
?
1
P-402 Clinical significance of micrometastasis detection in..:
Zhou, Qinghua
;
Youling, Gong
;
Zhiling, Sun
...
Lung Cancer. 41 (2003) - p. S193 , 2003
Link:
https://doi.org/10.1016/..
?
2
Preclinical study and phase II trial of adapting low-dose r..:
Wang, Hui
;
Yao, Zhuoran
;
Kang, Kai
...
Med. , 2024
Link:
https://doi.org/10.1016/..
?
3
Updated overall survival and circulating tumor DNA analysis..:
Zheng, Jing
;
Wang, Tao
;
Yang, Yunpeng
...
Cancer Communications. 44 (2024) 4 - p. 455-468 , 2024
Link:
https://doi.org/10.1002/..
?
4
First-line treatment of driver gene-negative metastatic lun..:
Zhao, Yuanyuan
;
Mei, Ting
;
Na, Feifei
...
Investigational New Drugs. 42 (2024) 2 - p. 196-206 , 2024
Link:
https://doi.org/10.1007/..
?
5
Pericardial irradiation dose may be strongly associated wit..:
Chen, Xianyan
;
Tian, Xiaoman
;
Zhang, Xuanwei
...
Thoracic Cancer. 14 (2023) 27 - p. 2735-2744 , 2023
Link:
https://doi.org/10.1111/..
?
6
The safety of combining immune checkpoint inhibitors and pl..:
Mei, Ting
;
Wang, Ting
;
Deng, Qianyue
.
Frontiers in Immunology. 14 (2023) - p. , 2023
Link:
https://doi.org/10.3389/..
?
7
The quality and clinical translation of radiomics studies b..:
Wang, Min
;
Mei, Ting
;
Gong, Youling
The British Journal of Radiology. 96 (2023) 1150 - p. , 2023
Link:
https://doi.org/10.1259/..
?
8
Involved-field irradiation or elective-nodal irradiation in..:
Chen, Xianyan
;
Zhang, Yingjie
;
Zhou, Xiaojuan
...
Frontiers in Oncology. 13 (2023) - p. , 2023
Link:
https://doi.org/10.3389/..
?
9
Real‐world clinical analysis in 190 advanced NSCLC patients..:
Qin, Yi
;
Long, Yaling
;
Tang, Yuan
...
Cancer Science. 114 (2023) 6 - p. 2552-2559 , 2023
Link:
https://doi.org/10.1111/..
?
10
Optimal timing of hypofractionated stereotactic radiotherap..:
Liang, Shimeng
;
Liu, Xiaoqin
;
Liu, Jia
...
Asia-Pacific Journal of Clinical Oncology. 19 (2023) 6 - p. 731-738 , 2023
Link:
https://doi.org/10.1111/..
?
11
Impact of antibiotic use before definitive concurrent chemo..:
Mei, Ting
;
Yang, Xuexi
;
Yu, Min
...
Strahlentherapie und Onkologie. 199 (2022) 7 - p. 645-657 , 2022
Link:
https://doi.org/10.1007/..
?
12
The impact of antibiotic selection and interval time among ..:
Tian, Xiaoman
;
Mei, Ting
;
Yu, Min
...
Cancer Medicine. 11 (2022) 24 - p. 4849-4864 , 2022
Link:
https://doi.org/10.1002/..
?
13
Discovery of potent and selective HER2 PROTAC degrader base..:
Hu, Mingxing
;
Li, Yujue
;
Li, Jiaxuan
...
European Journal of Medicinal Chemistry. 244 (2022) - p. 114775 , 2022
Link:
https://doi.org/10.1016/..
?
14
Discovery of highly potent and selective 7-ethyl-10-hydroxy..:
Yang, Chao
;
Xia, An-Jie
;
Du, Cheng-Hao
...
Frontiers in Pharmacology. 13 (2022) - p. , 2022
Link:
https://doi.org/10.3389/..
?
15
An overview of PROTACs: a promising drug discovery paradigm:
Liu, Zi
;
Hu, Mingxing
;
Yang, Yu
...
Molecular Biomedicine. 3 (2022) 1 - p. , 2022
Link:
https://doi.org/10.1186/..
1-15